# Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3

> **NCT07075445** · — · RECRUITING · sponsor: **Thryv Therapeutics, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Long QT Syndrome Type 3
- Long QT Syndrome 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07075445
- **Lead sponsor:** Thryv Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075445, "Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07075445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*